Research Program Portfolio

HomeProfessionalsResearchResearch Program Portfolio ▶ 2018 ATS Foundation Partner Grants
2018 ATS Foundation Partner Grants

Letter of intent forms are available on the Foundant Technologies Website.

PLEASE NOTE:
• Answers to frequently asked questions can be found in our FAQ; 
• Additional grants may be added below, subscribe to our mailing list for updates.

Anticipated Timeline

April 26, 2018 Letter of Intent Period Opens
June 19, 2018 Deadline for Letter of Intent due by 11:59pm Eastern Time
August 2018 Invitation from scientific Advisory Committee for Full Applications
September 20, 2018 Full Application Deadline due by 11:59pm Eastern Time
November 2018 Grantee Notification
December 2018 Grant Start Date

Current Partner Grant Opportunities

alpha1
ATS Foundation/Alpha-1 Foundation Research Grant
1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in research that is relevant to alpha-1 antitrypsin deficiency (Alpha-1)
The focus of this research grant is proposals that have a high likelihood to advance the understanding of Alpha-1. Applications are encouraged from faculty members at any stage of their academic career. Applicants may request up to $40,000 per year for two years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here) or established investigators at any stage in their career
• Applicants must not be current awardees of the Alpha-1 Foundation Research Program
• Must meet eligibility requirements for all grants found here
 Co-funded by the ATS Foundation and the Alpha-1 Foundation. Please visit alpha1.org for more information about our partner.
 
alamp
ATS Foundation/American Lung Association in Oregon Research Grant
1 grant available
$50,000 per year for 2 years
Target Audience:
Investigators working at Oregon-based institutions interested in research relevant to lung disease, sleep, and critical care

The focus of this research grant is basic science and patient-oriented research investigating lung disease, sleep, and critical care. Patient-oriented research is defined as research performed with human subjects (or on material of human origin such as tissues or other specimen). This area of research includes 1) disease mechanism; 2) therapeutic interventions; 3) clinical trials; and 4) the development of new technologies. Applicants may request up to $50,000/year for 2 years for salaries, supplies or a combination of these two. Indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility:
• Junior investigators (as defined here)
• Investigators must be based in Oregon
• Must meet eligibility requirements for all grants found here

Fully funded by the American Lung Association in Oregon. Please visit lung.org/associations/charters/mountain-pacific/ for more information about our partner.

 
 Boehringer Ingelheim Pharmaceuticals, Inc.
ATS Foundation/Boehringer Ingelheim Pharmaceuticals, Inc. Research Fellowship in Idiopathic Pulmonary Fibrosis
1 grant available
$50,000 per year for 2 years
Target Audience:
Investigators interested in research that is relevant to idiopathic pulmonary fibrosis
The focus of this research grant is proposals that advance research in the area of idiopathic pulmonary fibrosis. Applicants may request up to $50,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. 
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Fully funded by Boehringer Ingelheim Pharmaceuticals, Inc. Please visit boehringer-ingelheim.com for more information about our partner.
 
 chILD Foundation
ATS Foundation/Children's Interstitial Lung Disease Foundation Research Grant
1 grant available
$50,000 for 1 year
Target Audience:
Investigators interested in research relevant to Neuroendocrine Hyperplasia of Infancy (NEHI)
The focus of this research grant is to advance the understanding of the pathophysiology of this rare disease. Examples include research addressing the cell biology of neuroendocrine cells in the lung, interactions between neuroendocrine cells and other cells of the airway or alveoli, the relationship between neuroendocrine cells and signs/symptoms of NEHI, or other studies that further advance the understanding, diagnosis, or treatment of this rare disease. Applicants may request up to $50,000 for 1 year for salaries, supplies or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here) or established investigators at any stage in their career
• Must meet eligibility requirements for all grants found here
Co-funded by the ATS Foundation and chILD Foundation. Please visit child-foundation.org for more information about our partner.
 
 Fisher & Paykel
ATS Foundation/Fisher & Paykel Healthcare Ltd. Research Award in Respiratory Award in Respiratory Support with Nasal High Flow (NHF) in Patients with COPD
1 grant available
$50,000 per year for 2 years
Target Audience:
Investigators interested in research that is relevant to nasal high flow in patients with COPD
The focus of this research grant is proposals that advance research in respiratory support with nasal high flow (NHF) in patients with COPD. Applicants may request up to $50,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. 
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Fully funded by Fisher & Paykel. Please visit fphcare.com for more information about our partner.
 
 Insmed
ATS Foundation/Insmed Research Award in Non-Tuberculous Mycobacteria (NTM) Lung Disease
1 grant available
$50,000 for 1 year
Target Audience:
Investigators interested in research that is relevant to non-tuberculous mycobacteria (NTM) lung disease
The focus of this research grant is proposals that advance research in the area of non-tuberculous mycobacteria (NTM) lung disease. Applicants may request up to $50,000 for one year. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. 
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Fully funded by Insmed. Please visit insmed.com for more information about our partner.
 
hps
ATS Foundation/Mallinckrodt Pharmaceuticals Inc. Research Fellowship in Sarcoidosis
1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in research that is relevant to sarcoidosis
The focus of this research grant is proposals that advance research in the area of sarcoidosis. Applicants may request up to $40,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. 
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Fully funded by Mallinckrodt Pharmaceuticals Inc.  Please visit mallinckrodt.com for more information about our partner.
 
pha
ATS Foundation/Pulmonary Hypertension Association Research Fellowship 
1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in research in pulmonary arterial hypertension
The focus of this research grant is to support research into the pathophysiology of PAH, toward elucidating mechanistic pathways and identifying novel therapeutic targets or biomarkers in adult or pediatric pulmonary hypertension. The project should have potential applicability to human pulmonary vascular diseases. Investigators are also encouraged to connect through PHA's professional network, PH Clinicians and Researchers, during the course of their research. Applicants may request up to $40,000/year for 2 years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Co-funded by the ATS Foundation and the Pulmonary Hypertension Association (PHA). Please visit phaassociation.org  for more information about our partner.
 
pha
The Aldrighetti Research Award for Young Investigators
1 grant available
$40,000 per year for 2 years
Target Audience:
Investigators interested in research in pulmonary arterial hypertension
The focus of this research grant is to support the career of a young investigator who is likely to make a strong and sustained impact in PAH research. Proposals should investigate the pathophysiology of PAH, toward elucidating mechanistic pathways and identifying novel therapeutic targets or biomarkers in adult or pediatric pulmonary hypertension. The project should have potential applicability to human pulmonary vascular diseases. Investigators are also encouraged to connect through PHA's professional network, PH Clinicians and Researchers, during the course of their research. Applicants may request up to $40,000/year for 2 years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution.
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Sponsorship Support provided by Actelion Pharmaceuticals, Inc. through a partnership with the Pulmonary Hypertension Association. Please visit phaassociation.org  for more information about our partner.
 
ResMed
ATS Foundation/ResMed Research Fellowship in Sleep Disordered Breathing and PAP Therapy
1 grant available
$50,000 per year for 2 years
Target Audience:
Investigators interested in research that is relevant to sleep disordered breathing and PAP therapy
The focus of this research grant is proposals that advance research in sleep disordered breathing and PAP therapy and have potential applicability to human airway diseases. Applicants may request up to $50,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. 
Award-specific eligibility:
• Junior investigators (as defined here)
• Must meet eligibility requirements for all grants found here
Fully funded by ResMed. Please visit resmed.com for more information about our partner.
 

REVIEW PROCESS

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please makes sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Advisory Committee (SAC) will review the applications in November 2018. The membership of the SAC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.


ATS POLICY ON ADDITIONAL GRANT FUNDING

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SAC will assess degree of overlap. In case of significant scientific overlap the applicant will have to choose between the ATS Foundation research grant and the other grant. Budgetary overlap is not allowed.


If your question is not answered in the FAQ, contact the ATS Foundation Research Program at researchprogram@thoracic.org.

 

Last Reviewed: June 2018